Literature DB >> 3005794

Functionalized congeners of 1,3-dipropyl-8-phenylxanthine: potent antagonists for adenosine receptors that modulate membrane adenylate cyclase in pheochromocytoma cells, platelets and fat cells.

D Ukena, J W Daly, K L Kirk, K A Jacobson.   

Abstract

Six amine, amino acid and peptide derivatives derived from 1,3-dipropyl-8-(p-carboxymethylphenyl)xanthine, a functionalized congener of 1,3-dipropyl-8-phenylxanthine, have been investigated as antagonists at A2 adenosine receptors stimulatory to adenylate cyclase in membranes from rat pheochromocytoma PC 12 cells and human platelets and at A1 adenosine receptors inhibitory to adenylate cyclase from rat fat cells. The functionalized congeners and conjugates have affinity constants ranging from 80 to 310 nM at A2 receptors of PC 12 cells and from 25 to 135 nM at those of platelets. The affinity of the xanthine derivatives at A1 receptors of fat cells are in the 15 to 30 nM range. Thus, the amino acid and peptide conjugates have high potencies at both receptor subclasses and show some selectivity toward A1 adenosine receptors. Derivatives of the congeners should be useful as receptor probes and as radioiodinated ligands.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005794      PMCID: PMC4364026          DOI: 10.1016/0024-3205(86)90596-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  21 in total

1.  A novel 8-phenyl-substituted xanthine derivative is a selective antagonist at adenosine A1-receptors in vivo.

Authors:  K A Jakobson; K L Kirk; J W Daly; B Jonzon; Y O Li; B B Fredholm
Journal:  Acta Physiol Scand       Date:  1985-10

2.  Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis.

Authors:  C Londos; D M Cooper; W Schlegel; M Rodbell
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

3.  Effects of several 5'-carboxamide derivatives of adenosine on adenosine receptors of human platelets and rat fat cells.

Authors:  D Ukena; E Böhme; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-08       Impact factor: 3.000

4.  Adenosine antagonism by purines, pteridines and benzopteridines in human fibroblasts.

Authors:  R F Bruns
Journal:  Biochem Pharmacol       Date:  1981-02-15       Impact factor: 5.858

5.  Subclasses of external adenosine receptors.

Authors:  C Londos; D M Cooper; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

6.  Conjugates of catecholamines. II. In vitro and in vivo pharmacological activity of N-alkyl-functionalized carboxylic acid congeners and amides related to isoproterenol.

Authors:  R P Rosenkranz; B B Hoffman; K A Jacobson; M S Verlander; L Klevans; M O'Donnell; M Goodman; K L Melmon
Journal:  Mol Pharmacol       Date:  1983-11       Impact factor: 4.436

7.  Adenosine receptor binding: structure-activity analysis generates extremely potent xanthine antagonists.

Authors:  R F Bruns; J W Daly; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

8.  Probing the adenosine receptor with adenosine and xanthine biotin conjugates.

Authors:  K A Jacobson; K L Kirk; W Padgett; J W Daly
Journal:  FEBS Lett       Date:  1985-05-06       Impact factor: 4.124

9.  Preparation and characterization of a plasma membrane fraction from isolated fat cells.

Authors:  D W McKeel; L Jarett
Journal:  J Cell Biol       Date:  1970-02       Impact factor: 10.539

10.  Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors.

Authors:  K A Jacobson; K L Kirk; W L Padgett; J W Daly
Journal:  J Med Chem       Date:  1985-09       Impact factor: 7.446

View more
  24 in total

1.  Improvement of cold tolerance by selective A1 adenosine receptor antagonists in rats.

Authors:  T F Lee; D J Li; K A Jacobson; L C Wang
Journal:  Pharmacol Biochem Behav       Date:  1990-09       Impact factor: 3.533

Review 2.  Xanthines as adenosine receptor antagonists.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Handb Exp Pharmacol       Date:  2011

3.  Riboflavin: Inhibitory Effects on Receptors, G-Proteins, and Adenylate Cyclase.

Authors:  John W Daly; Dan Shi; William L Padgett; Xiao-Duo Ji; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1997-10-01       Impact factor: 4.360

Review 4.  Nomenclature and classification of purinoceptors.

Authors:  B B Fredholm; M P Abbracchio; G Burnstock; J W Daly; T K Harden; K A Jacobson; P Leff; M Williams
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

5.  XAC, a functionalized congener of 1,3-dialkylxanthine, antagonizes A1 adenosine receptor-mediated inhibition of renin secretion in vitro.

Authors:  P C Churchill; K A Jacobson; M C Churchill
Journal:  Arch Int Pharmacodyn Ther       Date:  1987-12

6.  A new high affinity, iodinated adenosine receptor antagonist as a radioligand/photoaffinity crosslinking probe.

Authors:  G L Stiles; K A Jacobson
Journal:  Mol Pharmacol       Date:  1987-08       Impact factor: 4.436

7.  Activation and Desensitization of Rat A3-Adenosine Receptors by Selective Adenosine Derivatives and Xanthine-7-Ribosides.

Authors:  Kyung-Sun Park; Carsten Hoffmann; Hea Ok Kim; William L Padgett; John W Daly; Roberta Brambilla; Cristina Motta; Maria P Abbracchio; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1998-06-01       Impact factor: 4.360

8.  Further characterization of the renovascular effects of N6-cyclohexyladenosine in the isolated perfused rat kidney.

Authors:  N F Rossi; P C Churchill; K A Jacobson; A E Leahy
Journal:  J Pharmacol Exp Ther       Date:  1987-03       Impact factor: 4.030

9.  A1- and A2-selective adenosine antagonists: in vivo characterization of cardiovascular effects.

Authors:  G Evoniuk; K A Jacobson; M T Shamim; J W Daly; R J Wurtman
Journal:  J Pharmacol Exp Ther       Date:  1987-09       Impact factor: 4.030

10.  1,3,8- and 1,3,7-substituted xanthines: relative potency as adenosine receptor antagonists at the frog neuromuscular junction.

Authors:  A M Sebastião; J A Ribeiro
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.